arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Nexentis Technologies Inc.

NXTS

$0.50 ▼ -0.04 (-8.24%) at close

8 Visible periods

31 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Weak

Neutral

auto_awesome

Analytical Summary

Nexentis Technologies Inc. shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap —

Dividend Yield —

Revenue Growth None

Op. Margin None

ROIC -26.3% ↗

FCF / Share $-3.37 ↘

Trailing P/E —

Price / Book 0.1x

FCF Yield —

Debt / Equity 0.05

info Valuation on last close. End-of-day price, Nov 5, 2026.

8-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$210.00K

↓ -20.3% —

Net Income Profit after all expenses

$-4.00M

↑ +22.9% —

FCF / Share Free cash flow per share

$-3.37

↓ -477.0% —

Long-Term Debt Long-term obligations

$8.39K

↓ -47.8% —

trending_up

Bullish Indicators

Debt to EquityDebt to Equity is in the top quartile (lower is better)

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↑

Financial Health →

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Revenue Growth YoY (%)	—	-20.3% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-354%)	-33.1% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-514%)	-10.1% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-226%)	88.6% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1008%)	32.1% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+301%)	-58.8% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-835%)	—
EPS Growth YoY (%)	—	—	-50.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—
Net Income Growth YoY (%)	22.9% Good ↑ Good Improving Year-over-year change in net income	20.4% Good ↑ Good Improving Year-over-year change in net income	-13.6% Weak ↑ Weak Improving Year-over-year change in net income	-19.1% Weak ↑ Weak Improving Year-over-year change in net income	-202.6% Weak ↑ Weak Improving Year-over-year change in net income	19.2% Good Good Year-over-year change in net income	-452.4% Weak Weak Year-over-year change in net income	—
FCF Growth YoY (%)	-477.0% Weak ↓ Weak Declining Year-over-year change in free cash flow	78.3% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	72.3% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	-447.7% Weak ↓ Weak Declining Year-over-year change in free cash flow	-238.2% Weak ↑ Weak Improving Year-over-year change in free cash flow	41.0% Excellent Excellent Year-over-year change in free cash flow	-1066.2% Weak Weak Year-over-year change in free cash flow	—
Revenue CAGR 3Y (%)	—	-21.7% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	4.3% Caution ↓ Caution Declining Compound annual revenue growth over 3 years	30.9% Excellent Excellent Compound annual revenue growth over 3 years	0.9% Weak Weak Compound annual revenue growth over 3 years	—	—	—
Revenue CAGR 5Y (%)	—	3.6% Caution Caution Compound annual revenue growth over 5 years	-9.2% Weak Weak Compound annual revenue growth over 5 years	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Operating Margin (%) (%)	—	—	—	—	—	—	—	-121.6% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-911%)
Effective Tax Rate (%) (%)	0.5% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—
Profit Margin (%) (%)	—	—	—	—	—	—	—	-83.7% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-797%)
FCF Margin (%) (%)	—	—	—	—	—	-343.9% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	-119.3% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%
FCF / Net Income (x)	0.95x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.66x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.50x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.90x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.86x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.50x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.64x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	1.43x Good Good Free cash flow relative to reported net income Optimal: > 1x

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Return on Invested Capital (%)	-26.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-71.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-92.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-78.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-57.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	253.7% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	425.1% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	-146.8% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%
Return on Capital (%) (%)	-20.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-79.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-104.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-89.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-61.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-196.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-290.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	-60.4% Weak Weak Operating profit relative to total assets Optimal: > 10%
Return on Common Equity (%) (%)	-25.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-267%)	-109.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-829%)	-100.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-771%)	-98.2% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-754%)	-74.4% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-596%)	—	—	-163.5% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1190%)

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Debt to Equity (x)	0.05x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-92%)	—	—	—	0.00x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	-0.06x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-109%)	-0.08x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-113%)	0.38x Good Good Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-36%)
Interest Coverage (x)	-54.94x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-270000.00x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-115.24x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-172.48x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-564.05x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-6.65x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-446.75x Weak Weak Operating income divided by interest expense Optimal: > 5x	-8.57x Weak Weak Operating income divided by interest expense Optimal: > 5x
Net Debt (USD)	$-3.09M	$-2.19M	$-4.45M	$-5.70M	$-6.73M	$-218.89K	$-261.40K	$-355.86K
Debt / EBITDA (x)	-0.18x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	-0.00x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.02x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.02x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.19x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Revenue per Share (USD)	—	$0.04	$0.22	$0.75	$0.19	$0.15	$0.12	$0.06
Basic EPS, GAAP (USD)	$-3.54	—	$5.43	$10.85	—	—	—	—
Free Cash Flow per Share (USD)	$-3.37	$-0.58	$-2.69	$-9.74	$-1.78	$-0.53	$-0.89	$-0.08
Book Value per Share (USD)	$5.77	$0.39	$2.19	$8.49	$2.31	$-0.27	$-0.26	$0.02
Tangible Book Value per Share (USD)	$1.91	$0.39	$2.19	$8.49	$2.31	$-0.27	$-0.26	$0.02
Basic Weighted Avg Shares (shares)	1.13M	5.85M	1.20M	528,776	2.34M	1.52M	1.42M	6.67M

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Working Capital (USD)	$4.58M	$2.51M	$4.69M	$5.56M	$6.30M	$-290.06K	$-199.21K	$192.98K
LT Debt (USD)	—	—	—	—	$8.39K	$16.06K	$22.18K	$60.80K
Total Equity (USD)	$16.01M	$4.75M	$6.48M	$5.85M	$6.48M	$-436.18K	$-381.07K	$218.23K

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Sales/Revenue/Turnover (USD)	—	$210.00K	$263.44K	$394.00K	$438.14K	$232.27K	$175.82K	$426.59K
Depreciation Expense (USD)	$71.00K	$18.00K	$20.84K	$54.72K	$57.20K	$45.20K	$27.35K	$75.59K
Net Income, GAAP (USD)	$-4.00M	$-5.19M	$-6.52M	$-5.74M	$-4.82M	$-1.59M	$-1.97M	$-356.89K
Operating Cash Flow (USD)	$-3.81M	$-3.42M	$-3.23M	$-5.10M	$-4.10M	$-798.74K	$-1.24M	$-506.50K

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 5 days ago 8 years · 32 quarters

Nexentis Technologies Inc.

Analytical Summary

8-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare NXTS with peers